Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AEterna clarifies Neovastat clinical development program

Feb. 18, 1997

Mechanism of antitumor effect of natural lipopolysaccharide

Feb. 18, 1997

Progen's lead compound shows promise for cancer/metastasis

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Human Genome Sciences discloses novel human polypeptide for cancer

Feb. 17, 1997

BASF focuses on dolastatin derivatives

Feb. 17, 1997

TK signal transduction modulators claimed by Sugen

Feb. 17, 1997

Biopharmaceutics/ABS form advisory team to advance filings for anticancer drug

Feb. 14, 1997

TK inhibitors disclosed by RCT

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...